Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.460
+0.050 (1.47%)
Mar 14, 2025, 11:29 AM EDT - Market open

Relay Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
5876901,3571,8063,3183,733
Upgrade
Market Cap Growth
-49.19%-49.19%-24.86%-45.57%-11.11%-
Upgrade
Enterprise Value
-155-1006018132,7253,043
Upgrade
Last Close Price
3.414.1211.0114.9430.7141.56
Upgrade
PS Ratio
48.6868.9153.131307.871095.4245.16
Upgrade
PB Ratio
0.740.891.801.903.704.89
Upgrade
P/TBV Ratio
0.890.891.811.913.714.89
Upgrade
EV/Sales Ratio
--23.53588.46899.5836.82
Upgrade
Debt / Equity Ratio
0.060.060.070.060.030.03
Upgrade
Asset Turnover
0.010.010.030.000.000.14
Upgrade
Quick Ratio
15.4015.4024.7815.7639.6055.80
Upgrade
Current Ratio
15.9515.9525.4416.0040.1456.49
Upgrade
Return on Equity (ROE)
-44.15%-44.15%-40.18%-31.44%-43.81%-9.35%
Upgrade
Return on Assets (ROA)
-28.11%-28.11%-24.40%-18.44%-15.63%-5.85%
Upgrade
Return on Capital (ROIC)
-29.54%-29.54%-26.15%-20.15%-16.54%-5.96%
Upgrade
Earnings Yield
-58.42%-48.97%-25.20%-16.08%-10.97%-1.40%
Upgrade
FCF Yield
-43.44%-36.42%-22.43%-13.21%-2.35%-2.80%
Upgrade
Buyback Yield / Dilution
-16.55%-16.55%-9.22%-17.97%-123.22%-1135.17%
Upgrade
Total Shareholder Return
-16.55%-16.55%-9.22%-17.97%-123.22%-1135.17%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.